119 related articles for article (PubMed ID: 9633834)
1. Neuropeptide Y-mediated enhancement of NMDA-stimulated [3H]dopamine release from rat prefrontal cortex is reversed by sigma1 receptor antagonists.
Ault DT; Werling LL
Schizophr Res; 1998 May; 31(1):27-36. PubMed ID: 9633834
[TBL] [Abstract][Full Text] [Related]
2. Differential modulation of NMDA-stimulated [3H]dopamine release from rat striatum by neuropeptide Y and sigma receptor ligands.
Ault DT; Werling LL
Brain Res; 1997 Jun; 760(1-2):210-7. PubMed ID: 9237537
[TBL] [Abstract][Full Text] [Related]
3. Modulation of [3H]Dopamine release from rat nucleus accumbens by neuropeptide Y may involve a sigma1-like receptor.
Ault DT; Radeff JM; Werling LL
J Pharmacol Exp Ther; 1998 Feb; 284(2):553-60. PubMed ID: 9454797
[TBL] [Abstract][Full Text] [Related]
4. sigma1 Receptors in rat striatum regulate NMDA-stimulated [3H]dopamine release via a presynaptic mechanism.
Gonzalez-Alvear GM; Werling LL
Eur J Pharmacol; 1995 Dec; 294(2-3):713-9. PubMed ID: 8750737
[TBL] [Abstract][Full Text] [Related]
5. Regulation of [3H] dopamine release from mesolimbic and mesocortical areas of guinea pig brain by sigma receptors.
Weatherspoon JK; Gonzalez-Alvear GM; Frank AR; Werling LL
Schizophr Res; 1996 Jul; 21(1):51-62. PubMed ID: 8998276
[TBL] [Abstract][Full Text] [Related]
6. Modulation of amphetamine-stimulated (transporter mediated) dopamine release in vitro by sigma2 receptor agonists and antagonists.
Izenwasser S; Thompson-Montgomery D; Deben SE; Chowdhury IN; Werling LL
Eur J Pharmacol; 1998 Apr; 346(2-3):189-96. PubMed ID: 9652359
[TBL] [Abstract][Full Text] [Related]
7. Release of [3H]dopamine from guinea pig striatal slices is modulated by sigma1 receptor agonists.
Gonzalez GM; Werling LL
Naunyn Schmiedebergs Arch Pharmacol; 1997 Oct; 356(4):455-61. PubMed ID: 9349631
[TBL] [Abstract][Full Text] [Related]
8. SH-SY5Y cells as a model for sigma receptor regulation of potassium-stimulated dopamine release.
Ault DT; Werling LL
Brain Res; 2000 Sep; 877(2):354-60. PubMed ID: 10986350
[TBL] [Abstract][Full Text] [Related]
9. Lack of effects by sigma ligands on neuropeptide Y-induced G-protein activation in rat hippocampus and cerebellum.
Hong W; Werling L
Brain Res; 2001 May; 901(1-2):208-18. PubMed ID: 11368969
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptide Y potentiates the N-methyl-D-aspartate response in the CA3 dorsal hippocampus. II. Involvement of a subtype of sigma receptor.
Monnet FP; Debonnel G; Fournier A; de Montigny C
J Pharmacol Exp Ther; 1992 Dec; 263(3):1219-25. PubMed ID: 1469630
[TBL] [Abstract][Full Text] [Related]
11. Sigma receptor regulation of norepinephrine release from rat hippocampal slices.
Gonzalez-Alvear GM; Werling LL
Brain Res; 1995 Feb; 673(1):61-9. PubMed ID: 7757480
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptide Y potentiates selectively the N-methyl-D-aspartate response in the rat CA3 dorsal hippocampus. I. Involvement of an atypical neuropeptide Y receptor.
Monnet FP; Fournier A; Debonnel G; de Montigny C
J Pharmacol Exp Ther; 1992 Dec; 263(3):1212-8. PubMed ID: 1469629
[TBL] [Abstract][Full Text] [Related]
13. Phencyclidine and dizocilpine modulate dopamine release from rat nucleus accumbens via sigma receptors.
Ault DT; Werling LL
Eur J Pharmacol; 1999 Dec; 386(2-3):145-53. PubMed ID: 10618464
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of sigma ligand-activated receptor subtypes that modulate NMDA-evoked [3H]-noradrenaline release in rat hippocampal slices.
Monnet FP; de Costa BR; Bowen WD
Br J Pharmacol; 1996 Sep; 119(1):65-72. PubMed ID: 8872358
[TBL] [Abstract][Full Text] [Related]
15. Sigma1 receptor agonist-mediated regulation of N-methyl-D-aspartate-stimulated [3H]dopamine release is dependent upon protein kinase C.
Nuwayhid SJ; Werling LL
J Pharmacol Exp Ther; 2003 Jan; 304(1):364-9. PubMed ID: 12490613
[TBL] [Abstract][Full Text] [Related]
16. Reversal by NPY, PYY and 3-36 molecular forms of NPY and PYY of intracisternal CRF-induced inhibition of gastric acid secretion in rats.
Gué M; Junien JL; Reeve JR; Rivier J; Grandt D; Taché Y
Br J Pharmacol; 1996 May; 118(2):237-42. PubMed ID: 8735621
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y-induced enhancement of the evoked release of newly synthesized dopamine in rat striatum: mediation by Y2 receptors.
Adewale AS; Macarthur H; Westfall TC
Neuropharmacology; 2007 May; 52(6):1396-402. PubMed ID: 17382974
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y (NPY) and peptide YY (PYY) effects in the epididymis of the guinea-pig: evidence of a pre-junctional PYY-selective receptor.
Haynes JM; Hill SJ; Selbie LA
Br J Pharmacol; 1997 Dec; 122(7):1530-6. PubMed ID: 9421306
[TBL] [Abstract][Full Text] [Related]
19. [Leu31-Pro34] neuropeptide Y identifies a subtype of 125I-labeled peptide YY binding sites in the rat brain.
Gehlert DR; Gackenheimer SL; Schober DA
Neurochem Int; 1992 Jul; 21(1):45-67. PubMed ID: 1303142
[TBL] [Abstract][Full Text] [Related]
20. Some of the effects of the selective sigma ligand (+)pentazocine are mediated via a naloxone-sensitive receptor.
Couture S; Debonnel G
Synapse; 2001 Mar; 39(4):323-31. PubMed ID: 11169783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
